Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer

A potential strategy for patients with estrogen receptor (ER)-positive breast cancer is necessary to replace neoadjuvant chemotherapy which has limited benefit. Neoadjuvant endocrine therapy (NAE) has been indicated to be a favorable alternate approach to downstage large or locally advanced breast c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Clin Cases
Autors principals: Yao, Li-Tong, Wang, Mo-Zhi, Wang, Meng-Shen, Yu, Xue-Ting, Guo, Jing-Yi, Sun, Tie, Li, Xin-Yan, Xu, Ying-Ying
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2019
Matèries:
Minireviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695538/
https://ncbi.nlm.nih.gov/pubmed/31423426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i15.1937
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars